ZA201003573B - Pharmaceutical composition containing a zeoliter/algae or zeolite/emulsion combination for the treatment of aids - Google Patents

Pharmaceutical composition containing a zeoliter/algae or zeolite/emulsion combination for the treatment of aids

Info

Publication number
ZA201003573B
ZA201003573B ZA2010/03573A ZA201003573A ZA201003573B ZA 201003573 B ZA201003573 B ZA 201003573B ZA 2010/03573 A ZA2010/03573 A ZA 2010/03573A ZA 201003573 A ZA201003573 A ZA 201003573A ZA 201003573 B ZA201003573 B ZA 201003573B
Authority
ZA
South Africa
Prior art keywords
zeoliter
algae
zeolite
aids
treatment
Prior art date
Application number
ZA2010/03573A
Inventor
Axel Siegner
Original Assignee
Neopharmacie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharmacie Gmbh filed Critical Neopharmacie Gmbh
Publication of ZA201003573B publication Critical patent/ZA201003573B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • AIDS & HIV (AREA)
  • Inorganic Chemistry (AREA)
ZA2010/03573A 2007-11-23 2010-05-20 Pharmaceutical composition containing a zeoliter/algae or zeolite/emulsion combination for the treatment of aids ZA201003573B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007056424A DE102007056424A1 (en) 2007-11-23 2007-11-23 Pharmaceutical composition containing an oil / water emulsion
PCT/EP2008/066033 WO2009065947A2 (en) 2007-11-23 2008-11-21 Pharmaceutical composition containing a zeolite/algae or zeolite/emulsion combination for the treatment of aids

Publications (1)

Publication Number Publication Date
ZA201003573B true ZA201003573B (en) 2011-04-28

Family

ID=40457343

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA2010/03574A ZA201003574B (en) 2007-11-23 2010-05-20 Pharmaceutical kit consisting of an oil-water emulsion and a solid composition
ZA2010/03573A ZA201003573B (en) 2007-11-23 2010-05-20 Pharmaceutical composition containing a zeoliter/algae or zeolite/emulsion combination for the treatment of aids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA2010/03574A ZA201003574B (en) 2007-11-23 2010-05-20 Pharmaceutical kit consisting of an oil-water emulsion and a solid composition

Country Status (6)

Country Link
EP (1) EP2259789A2 (en)
AP (2) AP2010005274A0 (en)
DE (1) DE102007056424A1 (en)
RU (2) RU2010125505A (en)
WO (2) WO2009065946A2 (en)
ZA (2) ZA201003574B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2545788A1 (en) * 2011-07-13 2013-01-16 Martin Hulliger Dietary multi-component system
RU2708161C1 (en) * 2019-04-16 2019-12-05 Иван Павлович Уваров Fodder complex biologically active additive for animals and birds

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
EP1063994A1 (en) * 1998-03-16 2001-01-03 The Procter & Gamble Company Method of treating skin irritation
DE19940011B4 (en) * 1999-08-24 2009-04-02 Schütte/Reichel GbR (vertretungsberechtigte Gesellschafter: Irene Schütte Alginate preparation and their use
US20060122082A1 (en) * 2000-02-17 2006-06-08 Leonard Paul Foam/spray producing compositions and dispensing system therefor
US20030216364A1 (en) * 2001-08-13 2003-11-20 Johnson Keith Arthur Dermatological Formulation
US20050058672A1 (en) * 2003-09-14 2005-03-17 Bioderm Research Baby Care Skin Protectant Compositions for Diaper Rash
BRPI0410503B8 (en) * 2003-04-24 2021-05-25 Galderma Sa topical composition and use of composition
US20040253323A1 (en) * 2003-06-11 2004-12-16 Giles Brian C. Ionic cancer therapy and methods for using same in the treatment of tumors and metastasis
US7485451B2 (en) * 2004-11-18 2009-02-03 Regents Of The University Of California Storage stable compositions of biological materials
DE102005009515A1 (en) * 2005-02-25 2006-09-07 Exner, Heinrich, Dr. A process for preparing a preparation of a DMSO-containing solid silicone oil emulsion for binding reactive oxygen compounds in the body of humans and animals
US20070031512A1 (en) * 2005-08-03 2007-02-08 Amcol International Corporation Virus-interacting layered phyllosilicates and methods of inactivating viruses
US20080260816A1 (en) * 2005-09-16 2008-10-23 Bengt Herslof Particulate Lipid Pharmaceutical Composition
EP1956920A1 (en) * 2005-11-22 2008-08-20 Nestec S.A. Easily dispersible lipidic phase
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
GB0602528D0 (en) * 2006-02-08 2006-03-22 Ici Plc Emulsification systems, emulsions and wet wipes containing such emulsions
US20100226932A1 (en) * 2006-02-22 2010-09-09 Novavax, Inc. Adjuvant and Vaccine Compositions
EP2001439A2 (en) * 2006-03-07 2008-12-17 Novavax, Inc. Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same

Also Published As

Publication number Publication date
WO2009065946A2 (en) 2009-05-28
WO2009065947A2 (en) 2009-05-28
AP2010005275A0 (en) 2010-06-30
RU2010125503A (en) 2011-12-27
AP2010005274A0 (en) 2010-06-30
DE102007056424A1 (en) 2009-05-28
EP2259789A2 (en) 2010-12-15
WO2009065947A3 (en) 2009-11-19
WO2009065946A3 (en) 2009-07-16
ZA201003574B (en) 2011-02-23
RU2010125505A (en) 2011-12-27
RU2496506C2 (en) 2013-10-27

Similar Documents

Publication Publication Date Title
IL195571A0 (en) Compounds for the treatment of periodontal disease
HK1131141A1 (en) Imidazolothiazole compounds for the treatment of disease
EP2040721A4 (en) Medicinal compositions containing honey
ME01944B (en) Pharmaceutical compositions containing rosuvastatin calcium
EP2124878A4 (en) Increased effectiveness of allylamine drug compounds
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
EP1976377A4 (en) Compounds for the treatment of metabolic disorders
PL1975226T3 (en) Liquid treatment composition
EP1983972A4 (en) Compounds for the treatment of metabolic disorders
IL192299A0 (en) Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
ZA200808963B (en) Compounds for the treatment of metabolic disorders
HK1132458A1 (en) Ophthalmic composition containing alginic acid or salt thereof
ZA200805645B (en) Compounds for the treatment of metabolic disorders
IL209360A (en) Pharmaceutical compositions comprising pm00104 for the treatment of multiple myeloma
EP2213303A4 (en) Pharmaceutical composition for treatment of cataract
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
EP2170049A4 (en) Compounds and compositions for the control of pests
IL192851A0 (en) Compounds for the treatment of metabolic disorders
ZA201003573B (en) Pharmaceutical composition containing a zeoliter/algae or zeolite/emulsion combination for the treatment of aids
IL195392A0 (en) Compounds for the treatment of metabolic disorders
HU0500685D0 (en) Pharmaceutical composition for the treatment of psychosis
GB0604782D0 (en) Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders
HK1120034A1 (en) Pharmaceuticals for treating or preventing oral diseases
IL192982A0 (en) Compounds for the treatment of metabolic disorders
EP2149549A4 (en) Pharmaceutical composition for prevention or treatment of hepatitis